中国女性绝经前后血脂变化轨迹:开滦队列研究结果
结果显示无论基线年龄,总胆固醇、低密度脂蛋白胆固醇和甘油三酯从过渡早期即开始升高,总胆固醇和低密度脂蛋白胆固醇在最终月经前1年至后2年增幅最大。
要点
- 总胆固醇、低密度脂蛋白胆固醇和甘油三酯从过渡早期开始升高,与基线年龄无关。
- 总胆固醇和低密度脂蛋白胆固醇在最终月经前1年至后2年年度增幅最大。
- 基线年龄≥45岁者高密度脂蛋白胆固醇在绝经后先降后升,<45岁者保持稳定。
核心结论
- 无论基线年龄,绝经对血脂的不良影响自过渡早期即出现,最显著变化时段为最终月经前1年至后2年。
- 高密度脂蛋白胆固醇在较年长女性绝经后先降后升;体重指数和最终月经年龄主要影响绝经后血脂轨迹。
- 作者强调绝经期积极血脂管理以减少绝经后血脂异常负担,体重指数和最终月经年龄是绝经后女性血脂分层管理的重要因素。
研究设计与样本
- 采用多变量分段线性混合效应模型分析血脂随最终月经前后时间的重复测量变化。
主要发现
- 总胆固醇、低密度脂蛋白胆固醇和甘油三酯从过渡早期开始升高,与基线年龄无关。
- 总胆固醇和低密度脂蛋白胆固醇在最终月经前1年至后2年年度增幅最大;甘油三酯在过渡早期至绝经后第4年年度增幅最大。
- 基线年龄<45岁时高密度脂蛋白胆固醇围绕最终月经保持稳定;基线年龄≥45岁时高密度脂蛋白胆固醇在绝经后先降后升。
- 体重指数较高女性绝经后总胆固醇和甘油三酯不良变化较少,绝经前高密度脂蛋白胆固醇下降。
- 最终月经年龄较晚与绝经后总胆固醇、低密度脂蛋白胆固醇和甘油三酯不良变化较少及高密度脂蛋白胆固醇升高幅度较大相关,与过渡早期低密度脂蛋白胆固醇升高幅度较大相关。
临床怎么用
- 作者强调绝经期积极血脂管理以减少绝经后血脂异常负担。
- 作者认为体重指数和最终月经年龄是绝经后女性血脂分层管理的重要因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate changes in lipid parameters around the final menstrual period (FMP) in Chinese women. DESIGN: A prospective community-based cohort study. PATIENT(S): Three thousand seven hundred fifty six Chinese women from the Kailuan cohort study who participated in the first examination and reached their FMP by the end of the seventh examination. Health examinations were performed every 2 years. Multivariable piece-wise linear mixed-effect models were used for repeated measures of lipids as a function of time around FMP. INTERVENTION(S): Number of years before or after FMP at each examination. MAIN OUTCOME MEASURE(S): Lipids at each examination, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TGs). RESULT(S): Total cholesterol, LDL-C, and TGs began to increase in early transition, regardless of baseline age. Moreover, TC and LDL-C had a maximum annual increase from 1 year before to 2 years after FMP; TGs had a maximum annual increase from early transition to the fourth-year after menopause. The trajectories in other postmenopause segments differed across subgroups of different baseline ages. Furthermore, HDL-C remained stable around FMP if baseline age was <45 years, whereas if baseline age was ≥45 years, HDL-C would first decline and then rise during postmenopause. Women with a higher body mass index (BMI) underwent less adverse changes in TC and TGs during postmenopause and had decline in HDL-C before menopause. A later FMP age was associated with less adverse changes in TC, LDL-C, and TGs and greater increase in HDL-C during postmenopause; it was associated with a greater increase in LDL-C during early transition. CONCLUSION(S): This repeated measurement cohort study of indigenous Chinese women demonstrated that, regardless of baseline age, the adverse effect of menopause on lipids was since early transition, and the most adverse change time was from 1 year before to 2 years after FMP; HDL-C decreased first and then increased during postmenopause in older women; BMI and FMP age affected lipid trajectory mainly during postmenopause. We highlighted positive lipid management during menopause to reduce the burden of postmenopausal dyslipidemia. For lipid stratification management in postmenopausal women, BMI and FMP age are important factors.
引用
- Dai Q, Wu S, Cao Z, et al. Trajectories of lipids around the menopause transition in Chinese women: results of the Kailuan cohort study. Fertil Steril. 2023. PMID: 36813125. doi:10.1016/j.fertnstert.2023.02.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。